CLINICAL_TRIALS
trial_result
· 2021-06-07
Clinical Trial Update: Phase 3 Study of Dexpramipexole in ALS [Phase 3]
Summary
A Phase 3 trial of dextramipexole for amyotrophic lateral sclerosis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Knopp Biosciences | Conditions: Amyotrophic Lateral Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2021-06-07